Stocks in news: Cipla, PC Jeweller, Shriram Finance, Grasim, Gland Pharma
Cipla said it has received the nod from Central Drugs Standard Control Organisation (CDSCO) for the exclusive distribution and marketing of Afrezza - inhalation human insulin in India.